NUGCX
Price
$37.45
Change
+$0.29 (+0.78%)
Updated
Oct 17 closing price
Net Assets
18.83M
RWIBX
Price
$74.19
Change
-$0.09 (-0.12%)
Updated
Oct 17 closing price
Net Assets
140.97B
Interact to see
Advertisement

NUGCX vs RWIBX

Header iconNUGCX vs RWIBX Comparison
Open Charts NUGCX vs RWIBXBanner chart's image
Nuveen Global Dividend Growth C
Price$37.45
Change+$0.29 (+0.78%)
VolumeN/A
Net Assets18.83M
American Funds Capital World Gr&Inc R2
Price$74.19
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets140.97B
NUGCX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
NUGCX vs. RWIBX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUGCX is a Buy and RWIBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 141B vs. NUGCX (18.8M). RWIBX pays higher dividends than NUGCX: RWIBX (0.76) vs NUGCX (0.44). NUGCX was incepted earlier than RWIBX: NUGCX (13 years) vs RWIBX (23 years). NUGCX (2.58) is less costly to investors than RWIBX (1.51). RWIBX is a more actively managed with annual turnover of: 27.00 vs. NUGCX (17.00). RWIBX has a lower initial minimum investment than NUGCX: RWIBX (250) vs NUGCX (2500). RWIBX annual gain was more profitable for investors over the last year : 9.87 vs. NUGCX (-0.63). RWIBX return over 5 years is better than : 46.31 vs. NUGCX (39.05).
NUGCXRWIBXNUGCX / RWIBX
Total Expense Ratio1.901.51126%
Annual Report Gross Expense Ratio2.581.51171%
Fund Existence13 years23 years-
Gain YTD9.58519.24750%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.8M141B0%
Annual Yield % from dividends0.440.7657%
Returns for 1 year-0.639.87-6%
Returns for 3 years41.9763.4266%
Returns for 5 years39.0546.3184%
Returns for 10 years54.3171.7076%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXSM127.942.94
+2.35%
Axsome Therapeutics
SCHW94.140.73
+0.78%
Charles Schwab Corp (The)
RNXT1.12-0.05
-4.27%
RenovoRx
CYD34.95-1.62
-4.43%
China Yuchai International Ltd
LFMD6.08-0.35
-5.44%
LifeMD